IHS Chemical Week

People & Business :: M&A

Report: Evonik among bidders for transdermal therapeutic system firm

August 1, 2013 | Francinia Protti-Alvarez

Evonik Industries is among the companies interested in bidding to acquire Lohmann Therapie-Systeme (LTS; Andernach, Germany), valued at an estimated €1 billion ($1.3 billion), according to a report from Bloomberg. Other potentially interested bidders include private equity firms EQT Partners (Stockholm), Nordic Capital (Stockholm), and BC Partners (London), the report adds. The private sale process for LTS is still in its early stages, the report says. The company is coowned by Novartis, SAP, cofounder Dietmar Hopp, and private equity firm BWK...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa